Latest antibodies Stories
Experimental Ebola vaccine developed by Public Health Agency of Canada OTTAWA, Nov.
MAB242P, the most recently developed antibody, is the first MBS antibody to recognize both GI and GII strains of norovirus.
MONROVIA, Calif., Nov. 4, 2014 /PRNewswire/ -- Xencor, Inc.
MONROVIA, Calif., Nov. 3, 2014 /PRNewswire/ -- Xencor, Inc.
Focusing development on rare autoimmune disorder IgG4-related disease (IgG4-RD) MONROVIA, Calif., Oct. 28, 2014 /PRNewswire/ -- Xencor, Inc.
Deal Expands Immuno-Oncology Product Discovery and Development Program and Aims to Accelerate Development of Oncology Therapeutics with Compelling Patient Benefit SOUTH SAN FRANCISCO,
Ebola detection kits for humans and animals are now possible using ADI antibody or antigen ELISA kits with results in less than 2 hours.
Broad Bi-Specific Antibody Collaboration Now Includes Targets that Could Lead to New Cancer Immunotherapies INDIANAPOLIS and VANCOUVER, Oct. 22, 2014 /CNW/ - Zymeworks Inc.
PhosImmune and PureMHC Working Together On Immunotherapies for Cancer CHARLOTTESVILLE, Va. and AUSTIN, Texas, Oct. 22, 2014 /PRNewswire/ -- PhosImmune Inc.
PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
- The governor of a province or people.
More Images (1 images) »